Gjalt Huisman
Investor at Baruch Future Ventures
About
Gjalt Huisman is a synthetic biology specialist with over 20 years of experience building R&D organizations and moving scientific innovation toward commercialization. He previously worked at Metabolix, Maxygen, and Codexis, where he led enzyme discovery for pharmaceuticals including atorvastatin, sitagliptin, and nirmatrelvir, and later established Codexis' biotherapeutics business. He holds MSc and PhD degrees from the University of Groningen and conducted post-doctoral work at Harvard Medical School, joining Baruch Future Ventures in 2023.
Invests in
Biotech